MSC-2940484A

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMSC-2940484A
Drug Alias NameDNA-PK inhibitor (Merck Serono)MSC-2940484A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA-dependent protein kinase inhibitors
TargetsDNA-dependent protein kinase
Therapy Area/IndicationsSolid tumoursHead and Neck Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Serono Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Serono Sa
Active IndicationsN/A
Inactive IndicationsSolid tumoursHead and Neck Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A